Literature DB >> 32017218

Update on rhinitis and rhinosinusitis.

Anna Maria Zicari1, Giovanna De Castro1, Lucia Leonardi1, Marzia Duse1.   

Abstract

Rhinitis is a common, under-diagnosed condition in childhood and adolescence. Pathogenic classification of rhinitis includes allergic rhinitis (AR) and non-allergic rhinitis (NAR); the latter is characterized by non-infectious and infectious subtypes; non-infectious subtype is by far the most prevalent in infancy. Endotyping may help to predict chronic rhinosinusitis (CRS) risk factors, as well as disease progression and response to different treatments. The validation of pediatric algorithms and the implementation of novel biotherapeutics in the endotype-driven integrated pathways of CRS will lead in the next future to more successful disease management.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  allergic rhinitis; children; chronic rhinosinusitis

Year:  2020        PMID: 32017218     DOI: 10.1111/pai.13164

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

1.  Treatment with a Probiotic Mixture Containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the Prevention of Allergic Rhinitis Symptoms in Children: A Randomized Controlled Trial.

Authors:  Caterina Anania; Vincenza Patrizia Di Marino; Francesca Olivero; Daniela De Canditiis; Giulia Brindisi; Federico Iannilli; Giovanna De Castro; Anna Maria Zicari; Marzia Duse
Journal:  Nutrients       Date:  2021-04-16       Impact factor: 5.717

2.  Tumor Suppressors-HTRA Proteases and Interleukin-12-in Pediatric Asthma and Allergic Rhinitis Patients.

Authors:  Joanna Renke; Eliza Wasilewska; Sabina Kędzierska-Mieszkowska; Katarzyna Zorena; Sylwia Barańska; Tomasz Wenta; Anna Liberek; Danuta Siluk; Dorota Żurawa-Janicka; Aleksandra Szczepankiewicz; Marcin Renke; Barbara Lipińska
Journal:  Medicina (Kaunas)       Date:  2020-06-17       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.